Skip to main content

Ali Naji

NIH Rank #80
  • Top 1% Funded
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1891347Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Genetics
  • Surgery
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$13.7M
Full award amounts, FY2026
Award Records
5
Records listing this PI
Award-Linked Rank
#80
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ali Naji. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Ali Naji as a PI. Multi-PI records show the full award amount for context.

  • 5U01DK123594-07U01
    Human Pancreas Analysis Program for Type 2 Diabetes (HPAP-T2D)
    $5M
    award amount
  • 5U01AI163087-06U01
    Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation
    $4.3M
    award amount
  • 5RC2DK139552-03RC2
    Epitranscriptomics in human obesity and type 2 diabetes
    $2M
    award amount
  • 5R01AI190177-02R01
    Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates
    $1.6M
    award amount
  • 5R01DK140741-03R01
    From Gut to Blood: Dissecting the mechanisms of CD4+ T cell pathology in islet autoimmunity across tissue environments.
    $811.8K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Ali Naji as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pennsylvania
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #133
  8. 2024
    Entered Top 25% Nationally
    Ranked #133
  9. 2024
    Entered Top 10% Nationally
    Ranked #133
  10. 2024
    Entered Top 5% Nationally
    Ranked #133
  11. 2024
    Entered Top 1% Nationally
    Ranked #133
  12. 2025
    $25M Cumulative Funding
  13. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  14. 2025
    R01 Grant Holder
  15. 2025
    Program/Center Grant Leader
  16. 2026
    $50M Cumulative Funding